| Financier | Commitments |
|---|---|
| IDA Grant | 7.50 |
Central African Republic COVID-19 Preparedness and Response Project
Abstract*
The purpose of the COVID-19 Preparedness and Response Project in the Central African Republic is to prepare for and respond to the threat posed by COVID-19 (Coronavirus). This project consists of three components. The first component is preparedness and response. This component will finance activities related to activities pertaining to preparedness, case management and response, including procurement of medical equipment and supplies, risk communication... Show More
Development Objective
To prepare for and respond to the threat posed by COVID-19 in the Central African Republic.
Key Details
Project Details
P173832
Closed
Innocent Nukuri , Tomo Morimoto
Central African Republic
April 20, 2020
(as of board presentation)
April 20, 2020
April 27, 2020
US$ 33.00 million
Ministry of Health and Population
2020
US$ 7.50 million
N/A
Substantial
June 30, 2024
No
BANK APPROVED
February 20, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 7.50 |
| IBRD + IDA Commitment | 7.50 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 33.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Feb 6, 2024 | IDA-D9790 | Loan Disb | 81,498.02 |
| Mar 2, 2021 | IDA-D6170 | Loan Disb | 240,640.00 |
| Apr 20, 2020 | IDA-D6170 | Loan Commitment | 7,500,000.00 |
| Feb 25, 2022 | IDA-D9790 | Loan Commitment | 25,500,000.00 |
| Jun 28, 2024 | IDA-D9790 | Loan Disb | -211,575.98 |
| Feb 14, 2024 | IDA-D9790 | Loan Disb | 45,683.74 |
| Feb 14, 2024 | IDA-D9790 | Loan Disb | 106,875.92 |
| Apr 24, 2024 | IDA-D9790 | Loan Cancel | 3,800,000.00 |
| Jun 25, 2024 | IDA-D9790 | Loan Disb | 506,541.28 |
| Jun 25, 2024 | IDA-D9790 | Loan Disb | 356,280.94 |
| Oct 30, 2023 | IDA-D9790 | Loan Disb | 2,726,898.00 |
| Jun 10, 2024 | IDA-D9790 | Loan Disb | 361,865.53 |
| Jun 27, 2023 | IDA-D9790 | Loan Disb | 37,030.43 |
| Sep 27, 2023 | IDA-D9790 | Loan Disb | 74,147.99 |
| Sep 14, 2023 | IDA-D9790 | Loan Disb | 498,078.97 |
| Jun 27, 2023 | IDA-D9790 | Loan Disb | 131,598.60 |
| Jun 12, 2023 | IDA-D9790 | Loan Disb | 10,597,392.00 |
| Jun 12, 2023 | IDA-D9790 | Loan Disb | 2,203,200.00 |
| Oct 20, 2023 | IDA-D6170 | Loan Disb | -3,069.80 |
| Sep 21, 2023 | IDA-D9790 | Loan Disb | 413,800.80 |
| Sep 5, 2023 | IDA-D9790 | Loan Disb | 164,328.89 |
| Jan 24, 2022 | IDA-D6170 | Loan Disb | 71,466.81 |
| Oct 12, 2022 | IDA-D9790 | Loan Disb | 2,241,482.20 |
| Nov 2, 2021 | IDA-D6170 | Loan Disb | 398,104.75 |
| Feb 23, 2021 | IDA-D6170 | Loan Disb | 369,985.62 |
| May 17, 2021 | IDA-D6170 | Loan Disb | 261,264.12 |
| Jun 11, 2020 | IDA-D6170 | Loan Disb | 520,637.44 |
| Jun 29, 2020 | IDA-D6170 | Loan Disb | 2,450,000.00 |
| Jun 16, 2020 | IDA-D6170 | Loan Disb | 1,636,418.50 |
| May 7, 2020 | IDA-D6170 | Loan Disb | 831,946.75 |
| Jul 27, 2020 | IDA-D6170 | Loan Disb | 152,774.70 |
| Sep 21, 2020 | IDA-D6170 | Loan Disb | 261,520.28 |
| Dec 8, 2020 | IDA-D6170 | Loan Disb | 463,877.16 |
| Feb 6, 2024 | IDA-D9790 | Loan Disb | 167,071.98 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Satisfactory | 2024-11-12 |
| Procurement | Satisfactory | 2024-11-12 |
| Project Management | Satisfactory | 2024-11-12 |
| Financial Management | Moderately Satisfactory | 2024-11-12 |
| Monitoring and Evaluation | Satisfactory | 2024-11-12 |
| Overall Implementation Progress (IP) | Satisfactory | 2024-11-12 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
COVID-19 risk communication messages broadcasted to communities (number of days) (Number, Custom) Value 0.00 474.00 90.00 Date April 27, 2020 December 14, 2023 June 30, 2024 Comment Health staff trained in infection prevention per MOH-approved protocols (Number, Custom) Value 0.00 516.00 500.00 Date April 27, 2020 December 14, 2023 June 30, 2024 Comment Personal protective equipment (PPE) kit (masks, face shield, gloves, gown) delivered to targeted health facilities (Number, Custom) Value 0.00 17250.00 9000.00 Date April 27, 2020 December 14, 2023 June 30, 2024 Comment Population vaccinated (Percentage, Custom) Value 13.00 80.00 70.00 Date February 8, 2022 December 14, 2023 June 30, 2024 Comment Proportion of women among those vaccinated (Percentage, Custom Supplement) Value 40.00 43.00 50.00 Date February 8, 2022 December 14, 2023 June 30, 2024 Comment Health staff trained in infection prevention per MOH-approved protocols Value 0.00 516.00 500.00 Date April 27, 2020 June 16, 2023 June 30, 2024 Comment Personal protective equipment (PPE) kit (masks, face shield, gloves, gown) delivered to targeted health facilities Value 0.00 17250.00 9000.00 Date April 27, 2020 June 16, 2023 June 30, 2024 Comment COVID-19 risk communication messages broadcasted to communities (number of days) Value 0.00 474.00 90.00 Date April 27, 2020 June 16, 2023 June 30, 2024 Comment Population vaccinated Value 13.00 80.00 70.00 Date February 8, 2022 December 14, 2023 June 30, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Districts with a mobile or out-reach facility to administer vaccines Value 0.00 35.00 25.00 Date February 25, 2022 June 16, 2023 June 30, 2024 Comment Consultation workshops with citizen groups and the media to overcome vaccine hesitancy and enable equitable access to vaccination services (per year) Value 0.00 0.00 2.00 Date February 25, 2022 June 16, 2023 June 30, 2024 Comment Targeted sites where solar-powered cold chain equipment has been installed and functional (Percentage, Custom Value 0.00 76.00 70.00 Date February 25, 2022 December 14, 2023 June 30, 2024 Comment Districts with community engagement plan implemented for increasing demand for COVID-19 vaccines by the population (Number, Custom) Value 0.00 35.00 25.00 Date February 25, 2022 December 14, 2023 June 30, 2024 Comment Additional patient "beds" made available in designated care centers and hospitals (Number, Custom) Value 0.00 73.00 70.00 Date April 27, 2020 December 14, 2023 June 30, 2024 Comment Laboratories with trained staff and consumables for collecting COVID-19 samples and transporting to Pasteur Institute laboratory (IBP) (Number, Custom) Value 1.00 91.00 15.00 Date April 27, 2020 December 14, 2023 June 30, 2024 Comment Targeted communities informed on hygiene behavior (Percentage, Custom) Value 0.00 100.00 90.00 Date April 27, 2020 December 14, 2023 June 30, 2024 Comment Doses of COVID-19 vaccines administered as a percentage of doses received (Percentage, Custom) Value 35.00 91.00 60.00 Date February 25, 2022 December 14, 2023 June 30, 2024 Comment Risk comminication strategy developed and disseminated (Yes/No, Custom) Value No Yes Yes Date April 27, 2020 December 14, 2023 June 30, 2024 Comment Targeted facilities that have received selected drugs required to respond to the surge in patients due to COVID-19 (Percentage, Custom) Value 0.00 100.00 90.00 Date April 27, 2020 December 14, 2023 June 30, 2024 Comment Share of vaccinators who are female (Percentage, Custom) Value 3.00 38.00 30.00 Date January 31, 2022 December 14, 2023 June 30, 2024 Comment Districts reached by gender-sensitive messages/materials disseminated of public communications and advocacy on COVID-19 vaccination(Number, Custom) Value 0.00 35.00 25.00 Date February 25, 2022 December 14, 2023 June 30, 2024 Comment M&E system established to monitor COVID-19 preparedness and response (Yes/No, Custom) Value No Yes Yes Date April 27, 2020 December 14, 2023 June 30, 2024 Comment Districts in which the vaccination deployment strategy targets areas where women congregate (Number, Custom) Value 0.00 35.00 25.00 Date February 25, 2022 December 14, 2023 June 30, 2024 Comment Districts with a mobile or out-reach facility to administer vaccines (Number, Custom) Value 0.00 35.00 25.00 Date February 25, 2022 December 14, 2023 June 30, 2024 Comment Consultation workshops with citizen groups and the media to overcome vaccine hesitancy and enable equitable access to vaccination services (per year) (Number, Custom) Value 0.00 1.00 2.00 Date February 25, 2022 December 14, 2023 June 30, 2024 Comment Standard operational procedures (SOP) for collection and disposal of medical waste developed and shared with relevant stakeholders (Yes/No, Custom) Value No Yes Yes Date January 31, 2022 December 14, 2023 June 30, 2024 Comment M&E system established to monitor COVID-19 preparedness and response Value No Yes Yes Date April 27, 2020 June 16, 2023 June 30, 2024 Comment Additional patient "beds" made available in designated care centers and hospitals Value 0.00 73.00 70.00 Date April 27, 2020 June 16, 2023 June 30, 2024 Comment Standard operational procedures (SOP) for collection and disposal of medical waste developed and shared with relevant stakeholders Value No Yes Yes Date January 31, 2022 June 16, 2023 June 30, 2024 Comment Laboratories with trained staff and consumables for collecting COVID-19 samples and transporting to Pasteur Institute laboratory (IBP) Value 1.00 91.00 15.00 Date April 27, 2020 June 16, 2023 June 30, 2024 Comment Risk comminication strategy developed and disseminated Value No Yes Yes Date April 27, 2020 June 16, 2023 June 30, 2024 Comment Targeted facilities that have received selected drugs required to respond to the surge in patients due to COVID-19 Value 0.00 100.00 90.00 Date April 27, 2020 December 30, 2022 June 30, 2022 Comment Targeted communities informed on hygiene behavior Value 0.00 100.00 90.00 Date April 27, 2020 June 16, 2023 June 30, 2024 Comment Doses of COVID-19 vaccines administered as a percentage of doses received Value 35.00 91.00 60.00 Date February 25, 2022 June 16, 2023 June 30, 2024 Comment Share of vaccinators who are female Value 3.00 38.00 30.00 Date January 31, 2022 June 16, 2023 June 30, 2024 Comment Districts in which the vaccination deployment strategy targets areas where women congregate Value 0.00 35.00 25.00 Date February 25, 2022 June 16, 2023 June 30, 2024 Comment Targeted sites where solar-powered cold chain equipment has been installed and functional Value 0.00 76.00 90.00 Date February 25, 2022 June 16, 2023 June 30, 2024 Comment Districts reached by gender-sensitive messages/materials disseminated of public communications and advocacy on COVID-19 vaccination Value 0.00 35.00 25.00 Date February 25, 2022 June 16, 2023 June 30, 2024 Comment Districts with community engagement plan implemented for increasing demand for COVID-19 vaccines by the population Value 0.00 35.00 25.00 Date February 25, 2022 June 16, 2023 June 30, 2024 Comment